MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net (decrease)increase in cash and cash...-$170,836K Accrued expenses andother current...$4,578K Stock-based compensation$4,295K Operating leaseliabilities$68K Depreciation expense$12K Net cash used ininvesting activities-$148,708K Net cash used inoperating activities-$22,124K Effect on exchangerates on cash and cash...-$4K Canceled cashflow$8,953K Purchases of investments$148,592K Payment of securitydeposit$59K Purchases of property andequipment$57K Net loss-$25,175K Accounts payable-$4,878K Prepaid expenses andother current assets$413K Related party accruedexpenses and other...-$332K Accretion/amortization on investments$174K Non-cash lease expense-$17K
Cash Flow
source: myfinsight.com

Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO)